Your browser doesn't support javascript.
loading
Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
Tagini, Florian; Carrel, Lionel; Fallet, Benedict; Gachoud, David; Ribi, Camillo; Monti, Matteo.
Affiliation
  • Tagini F; Division of Internal Medicine.
  • Carrel L; Division of Internal Medicine.
  • Fallet B; Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  • Gachoud D; Division of Internal Medicine.
  • Ribi C; Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  • Monti M; Division of Internal Medicine.
Rheumatology (Oxford) ; 61(5): e112-e113, 2022 05 05.
Article in En | MEDLINE | ID: mdl-34617989
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Behcet Syndrome / COVID-19 / 2019-nCoV Vaccine mRNA-1273 Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Behcet Syndrome / COVID-19 / 2019-nCoV Vaccine mRNA-1273 Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Document type: Article